Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Plos One
|
September 12, 2024
Hit screening with multivariate robust outlier detection
Hui Sun Leong, Tianhui Zhang, Adam Corrigan, et al.
AAPS Pharmscitech
|
June 25, 2009
A two one-sided parametric tolerance interval test for control of delivered dose uniformity--part 3--investigation of robustness to deviations from normality
Steven Novick, David Christopher, Monisha Dey, et al.
AAPS Pharmscitech
|
June 25, 2009
A two one-sided parametric tolerance interval test for control of delivered dose uniformity. Part 1--characterization of FDA proposed test
Steven Novick, David Christopher, Monisha Dey, et al.
Journal of Biomolecular Screening
|
June 21, 2013
The effect of initial purity on the stability of solutions in storage
Ioana Popa-Burke, Steven Novick, Charles A Lane, et al.
Pharmaceutical Statistics
|
May 30, 2019
Detecting bliss synergy in in vivo combination studies with a tumor kinetic model
Wei Zhao, Paolo Vicini, Steven Novick, et al.
Journal of Cancer Research and Clinical Oncology
|
September 24, 2013
Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study
Andreas Hochhaus, Philipp D le Coutre, Hagop M Kantarjian, et al.
ACS Chemical Biology
|
March 21, 2024
Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3
Heng Zhao, Praveen Kumar, Tiago Jose Paschoal Sobreira, et al.
Journal of Cancer Research and Clinical Oncology
|
May 24, 2015
Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study
Andreas Hochhaus, Michele Baccarani, Francis J Giles, et al.
Microorganisms
|
July 2, 2021
Engraftment of Bacteria after Fecal Microbiota Transplantation Is Dependent on Both Frequency of Dosing and Duration of Preparative Antibiotic Regimen
Vancheswaran Gopalakrishnan, Elizabeth Ashley Dozier, Matthew S Glover, et al.
Clinical Pharmacokinetics
|
July 24, 2019
Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies
Ken Ogasawara, Kathryn Newhall, Stephen E Maxwell, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Plos One
|
September 12, 2024
Hit screening with multivariate robust outlier detection
Hui Sun Leong, Tianhui Zhang, Adam Corrigan, et al.
AAPS Pharmscitech
|
June 25, 2009
A two one-sided parametric tolerance interval test for control of delivered dose uniformity--part 3--investigation of robustness to deviations from normality
Steven Novick, David Christopher, Monisha Dey, et al.
AAPS Pharmscitech
|
June 25, 2009
A two one-sided parametric tolerance interval test for control of delivered dose uniformity. Part 1--characterization of FDA proposed test
Steven Novick, David Christopher, Monisha Dey, et al.
Journal of Biomolecular Screening
|
June 21, 2013
The effect of initial purity on the stability of solutions in storage
Ioana Popa-Burke, Steven Novick, Charles A Lane, et al.
Pharmaceutical Statistics
|
May 30, 2019
Detecting bliss synergy in in vivo combination studies with a tumor kinetic model
Wei Zhao, Paolo Vicini, Steven Novick, et al.
Journal of Cancer Research and Clinical Oncology
|
September 24, 2013
Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study
Andreas Hochhaus, Philipp D le Coutre, Hagop M Kantarjian, et al.
ACS Chemical Biology
|
March 21, 2024
Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3
Heng Zhao, Praveen Kumar, Tiago Jose Paschoal Sobreira, et al.
Journal of Cancer Research and Clinical Oncology
|
May 24, 2015
Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study
Andreas Hochhaus, Michele Baccarani, Francis J Giles, et al.
Microorganisms
|
July 2, 2021
Engraftment of Bacteria after Fecal Microbiota Transplantation Is Dependent on Both Frequency of Dosing and Duration of Preparative Antibiotic Regimen
Vancheswaran Gopalakrishnan, Elizabeth Ashley Dozier, Matthew S Glover, et al.
Clinical Pharmacokinetics
|
July 24, 2019
Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies
Ken Ogasawara, Kathryn Newhall, Stephen E Maxwell, et al.
Page
of 4